PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$22.65
+0.54 (+2.44%)
Open$22.32
Previous Close$22.11
Day High$22.81
Day Low$22.12
52W High$27.64
52W Low$18.80
Volume—
Avg Volume750.3K
Market Cap913.86M
P/E Ratio129.92
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Buy
13 analysts
Price Target
+0.3% upside
Current
$22.65
$22.65
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 633.63M | 615.77M | 216.59M |
| Net Income | 6.14M | 5.37M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 60.08M | 55.47M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |